1-9 of 9
Paul-Gerhardt Schlegel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multinational Retrospective Analysis of Bridging Therapy Prior to Chimeric Antigen Receptor T Cells for Relapsed/Refractory Acute Lymphoblastic Leukemia in Children and Young Adults

Maike Breidenbach, Peter Bader, Andishe Attarbaschi, Claudia Rossig, Roland Meisel, Markus Metzler, Marion Subklewe, Fabian Mueller, Paul-Gerhardt Schlegel, Irene Teichert von Lüttichau, Jean-Pierre Bourquin, Gabriele Escherich, Gunnar Cario, Peter Lang, Ramona Krauss, Arend von Stackelberg, Semjon Willier, Christina Peters, Tobias Feuchtinger
Journal: Blood
Blood (2023) 142 (Supplement 1): 2135.
https://doi.org/10.1182/blood-2023-190117
Published: 2023
Journal Articles

CD19-CAR-T Cells Are Effective and Safe Treatment of Post-Transplant Relapse in Pediatric and Young Adult Patients with B-Lineage ALL: Real-World Data from Germany

Peter Bader, Claudia Rossig, Martin Hutter, Francis A. Ayuk, Claudia D. Baldus, Veit L Buecklein, Halvard Bonig, Gunnar Cario, Hermann Einsele, Udo Holtick, Christian Koenecke, Annette Künkele, Roland Meisel, Fabian Mueller, Ingo Müller, Olaf Penack, Eva Rettinger, Martin G. Sauer, Paul-Gerhardt Schlegel, Jan Soerensen, Arend von Stackelberg, Tobias Feuchtinger, Andrea Jarisch
Journal: Blood
Blood (2022) 140 (Supplement 1): 10407–10409.
https://doi.org/10.1182/blood-2022-156775
Published: 2022
Journal Articles

Blinatumomab in Children with Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia (R/R-ALL): Final Results of 110 Patients Treated in an Expanded Access Study (RIALTO)

Franco Locatelli, MD PhD, Gerhard Zugmaier, Noemi Mergen, MD, Peter Bader, MD, Sima Jeha, MD, Paul-Gerhardt Schlegel, Jean-Pierre Bourquin, MD PhD, Rupert Handgretinger, MD, Benoit Brethon, MD, Claudia Rössig, William Kormany, MD, Puneeth Viswagnachar, Christiane Chen-Santel
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-141336
Published: 2020
Journal Articles

Blinatumomab in Pediatric Patients with Relapsed/Refractory B-Cell Precursor and Molecularly Resistant Acute Lymphoblastic Leukemia (R/R ALL): Updated Analysis of 110 Patients Treated in an Expanded Access Study (RIALTO)

Franco Locatelli, MD, Gerhard Zugmaier, Peter Bader, MD, Sima Jeha, MD, Paul-Gerhardt Schlegel, Jean-Pierre Bourquin, MD PhD, Rupert Handgretinger, MD, Benoit Brethon, MD, Claudia Rossig, Christiane Chen-Santel
Journal: Blood
Blood (2019) 134 (Supplement_1): 1294.
https://doi.org/10.1182/blood-2019-121615
Published: 2019
Journal Articles

High Molecular Remission Rate in Pediatric Patients (pts) with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (r/r ALL) Treated with Blinatumomab: Rialto an Open-Label, Multicenter, Expanded Access Study

Franco Locatelli, Gerhard Zugmaier, Peter Bader, MD PhD, Sima Jeha, MD, Paul-Gerhardt Schlegel, MD, Jean-Pierre Bourquin, MD PhD, Rupert Handgretinger, MD PhD, Benoit Brethon, Claudia Rossig, MD, Christiane Chen-Santel, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1375.
https://doi.org/10.1182/blood-2018-99-109855
Published: 2018
Journal Articles

Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT

Clinical Trials & Observations
Judith Feucht, Kathrin Opherk, Peter Lang, Simone Kayser, Lena Hartl, Wolfgang Bethge, Susanne Matthes-Martin, Peter Bader, Michael H. Albert, Britta Maecker-Kolhoff, Johann Greil, Hermann Einsele, Paul-Gerhardt Schlegel, Friedhelm R. Schuster, Bernhard Kremens, Claudia Rossig, Bernd Gruhn, Rupert Handgretinger, Tobias Feuchtinger
Journal: Blood
Blood (2015) 125 (12): 1986–1994.
https://doi.org/10.1182/blood-2014-06-573725
Published: 2015
Includes: Supplemental data
Journal Articles

TGFβ and IL10 Have an Impact on Risk Group and Prognosis in Childhood ALL

Verena Wiegering, MD, Julia Taschik, MS, Imme Haubitz, Matthias Eyrich, PhD MD, Beate Winkler, Paul Gerhardt Schlegel
Journal: Blood
Blood (2014) 124 (21): 5337.
https://doi.org/10.1182/blood.V124.21.5337.5337
Published: 2014
Journal Articles

Initial Results from a Phase 2 Study of Blinatumomab in Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

Lia Gore, Franco Locatelli, Gerhard Zugmaier, Christian M. Zwaan, Deepa Bhojwani, Rupert Handgretinger, Peter Bader, Maureen M. O'Brien, Tanya M. Trippett, Benoît Brethon, Carmelo Rizzari, Steven G. DuBois, Paul Gerhardt Schlegel, Phillip Barnette, Chiara Messina, Kuolung Hu, Noemi Mergen, Anja Fischer, James Whitlock, Arend von Stackelberg
Journal: Blood
Blood (2014) 124 (21): 3703.
https://doi.org/10.1182/blood.V124.21.3703.3703
Published: 2014
Journal Articles

Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation

Clinical Trials & Observations
Eva Rettinger, Andre M. Willasch, Hermann Kreyenberg, Arndt Borkhardt, Wolfgang Holter, Bernhard Kremens, Brigitte Strahm, Wilhelm Woessmann, Christine Mauz-Koerholz, Bernd Gruhn, Stefan Burdach, Michael H. Albert, Paul-Gerhardt Schlegel, Thomas Klingebiel, Peter Bader
Journal: Blood
Blood (2011) 118 (20): 5681–5688.
https://doi.org/10.1182/blood-2011-04-348805
Published: 2011
Includes: Supplemental data